These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26928328)

  • 1. Coordinated Activation of Toll-Like Receptor8 (TLR8) and NLRP3 by the TLR8 Agonist, VTX-2337, Ignites Tumoricidal Natural Killer Cell Activity.
    Dietsch GN; Lu H; Yang Y; Morishima C; Chow LQ; Disis ML; Hershberg RM
    PLoS One; 2016; 11(2):e0148764. PubMed ID: 26928328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VTX-2337 is a novel TLR8 agonist that activates NK cells and augments ADCC.
    Lu H; Dietsch GN; Matthews MA; Yang Y; Ghanekar S; Inokuma M; Suni M; Maino VC; Henderson KE; Howbert JJ; Disis ML; Hershberg RM
    Clin Cancer Res; 2012 Jan; 18(2):499-509. PubMed ID: 22128302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLR8 stimulation enhances cetuximab-mediated natural killer cell lysis of head and neck cancer cells and dendritic cell cross-priming of EGFR-specific CD8+ T cells.
    Stephenson RM; Lim CM; Matthews M; Dietsch G; Hershberg R; Ferris RL
    Cancer Immunol Immunother; 2013 Aug; 62(8):1347-57. PubMed ID: 23685782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase Ib Trial of the Toll-like Receptor 8 Agonist, Motolimod (VTX-2337), Combined with Cetuximab in Patients with Recurrent or Metastatic SCCHN.
    Chow LQM; Morishima C; Eaton KD; Baik CS; Goulart BH; Anderson LN; Manjarrez KL; Dietsch GN; Bryan JK; Hershberg RM; Disis ML; Martins RG
    Clin Cancer Res; 2017 May; 23(10):2442-2450. PubMed ID: 27810904
    [No Abstract]   [Full Text] [Related]  

  • 5. The anti-tumor effects of cetuximab in combination with VTX-2337 are T cell dependent.
    Cheng Y; Borcherding N; Ogunsakin A; Lemke-Miltner CD; Gibson-Corley KN; Rajan A; Choi AB; Wongpattaraworakul W; Chan CHF; Salem AK; Weiner GJ; Simons AL
    Sci Rep; 2021 Jan; 11(1):1535. PubMed ID: 33452311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late-Stage Cancer Patients Remain Highly Responsive to Immune Activation by the Selective TLR8 Agonist Motolimod (VTX-2337).
    Dietsch GN; Randall TD; Gottardo R; Northfelt DW; Ramanathan RK; Cohen PA; Manjarrez KL; Newkirk M; Bryan JK; Hershberg RM
    Clin Cancer Res; 2015 Dec; 21(24):5445-52. PubMed ID: 26152744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ultra-potent and selective TLR8 agonist VTX-294 activates human newborn and adult leukocytes.
    Dowling DJ; Tan Z; Prokopowicz ZM; Palmer CD; Matthews MA; Dietsch GN; Hershberg RM; Levy O
    PLoS One; 2013; 8(3):e58164. PubMed ID: 23483986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 infection induces interleukin-1β production via TLR8 protein-dependent and NLRP3 inflammasome mechanisms in human monocytes.
    Guo H; Gao J; Taxman DJ; Ting JP; Su L
    J Biol Chem; 2014 Aug; 289(31):21716-26. PubMed ID: 24939850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aloe vera downregulates LPS-induced inflammatory cytokine production and expression of NLRP3 inflammasome in human macrophages.
    Budai MM; Varga A; Milesz S; Tőzsér J; Benkő S
    Mol Immunol; 2013 Dec; 56(4):471-9. PubMed ID: 23911403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cetuximab therapy in head and neck cancer: immune modulation with interleukin-12 and other natural killer cell-activating cytokines.
    Luedke E; Jaime-Ramirez AC; Bhave N; Roda J; Choudhary MM; Kumar B; Teknos TN; Carson WE
    Surgery; 2012 Sep; 152(3):431-40. PubMed ID: 22770960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EV71 3D Protein Binds with NLRP3 and Enhances the Assembly of Inflammasome Complex.
    Wang W; Xiao F; Wan P; Pan P; Zhang Y; Liu F; Wu K; Liu Y; Wu J
    PLoS Pathog; 2017 Jan; 13(1):e1006123. PubMed ID: 28060938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TLR and NLRP3 inflammasome-dependent innate immune responses to tumor-derived autophagosomes (DRibbles).
    Xing Y; Cao R; Hu HM
    Cell Death Dis; 2016 Aug; 7(8):e2322. PubMed ID: 27490927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway.
    Niemi K; Teirilä L; Lappalainen J; Rajamäki K; Baumann MH; Öörni K; Wolff H; Kovanen PT; Matikainen S; Eklund KK
    J Immunol; 2011 Jun; 186(11):6119-28. PubMed ID: 21508263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of cytokine-producing and antitumor activities of natural killer cells and macrophages by engagement of Toll-like and NOD-like receptors.
    Qiu F; Maniar A; Diaz MQ; Chapoval AI; Medvedev AE
    Innate Immun; 2011 Aug; 17(4):375-87. PubMed ID: 20682587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactive oxygen species activated NLRP3 inflammasomes prime environment-induced murine dry eye.
    Zheng Q; Ren Y; Reinach PS; She Y; Xiao B; Hua S; Qu J; Chen W
    Exp Eye Res; 2014 Aug; 125():1-8. PubMed ID: 24836981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56
    Veneziani I; Alicata C; Pelosi A; Landolina N; Ricci B; D'Oria V; Fagotti A; Scambia G; Moretta L; Maggi E
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35091452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NOD-Like Receptor Family Pyrin Domain-Containing 3 Inflammasome Activation Exacerbates 5-Fluorouracil-Induced Small Intestinal Mucositis via Interleukin-1β Activation.
    Nakata A; Nadatani Y; Watanabe T; Matsumoto Y; Kosaka S; Higashimori A; Otani K; Hosomi S; Tanaka F; Kamata N; Taira K; Nagami Y; Tanigawa T; Fujiwara Y
    Digestion; 2021; 102(2):298-312. PubMed ID: 31846964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production.
    Yu X; Lan P; Hou X; Han Q; Lu N; Li T; Jiao C; Zhang J; Zhang C; Tian Z
    J Hepatol; 2017 Apr; 66(4):693-702. PubMed ID: 28027970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Nlrp3 Inflammasome Suppresses Colorectal Cancer Metastatic Growth in the Liver by Promoting Natural Killer Cell Tumoricidal Activity.
    Dupaul-Chicoine J; Arabzadeh A; Dagenais M; Douglas T; Champagne C; Morizot A; Rodrigue-Gervais IG; Breton V; Colpitts SL; Beauchemin N; Saleh M
    Immunity; 2015 Oct; 43(4):751-63. PubMed ID: 26384545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori induces IL-1β and IL-18 production in human monocytic cell line through activation of NLRP3 inflammasome via ROS signaling pathway.
    Li X; Liu S; Luo J; Liu A; Tang S; Liu S; Yu M; Zhang Y
    Pathog Dis; 2015 Jun; 73(4):. PubMed ID: 25834143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.